Peficitinib

944118-01-8

JAK|||Tyrosine Kinases

Tyrosine Kinase/Adaptors|||JAK/STAT signaling|||Chromatin/Epigenetic|||Stem Cells|||Angiogenesis

0.9984

Peficitinib (ASP015K) (ASP015K, JNJ-54781532) is an orally bioavailable JAK inhibitor. Phase 3.

[H][C@]12CC3C[C@]([H])(CC(O)(C3)C1)C2Nc1c(cnc2[nH]ccc12)C(N)=O

C18H22N4O2

326.39

Cool pack

-20°C